Canton Strategic Holdings (CNTN) Non Operating Income (2021 - 2026)
Canton Strategic Holdings posted quarterly Non Operating Income of -$14.7 million for Q1 2026, down 296074.34% year-on-year from N/an in Q1 2025, and up 33.17% on a QoQ basis from -$22.0 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 6 years of Non Operating Income data on file, last reported at -$14.7 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 296074.34% year-over-year to -$14.7 million; the trailing twelve-month figure through Mar 2026 stood at -$36.7 million (down 24565.74% YoY), and the FY2025 full-year result was -$22.0 million, down 9412.05% from the prior year.
- Non Operating Income for Q1 2026 stood at -$14.7 million, up from -$22.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $91194.0 in Q1 2024 and bottomed at -$22.0 million in Q4 2025.
- The 5-year median for Non Operating Income is $25532.5 (2023), against an average of -$2.7 million.
- The widest annual swing landed in 2024, when Non Operating Income soared 249.27%; it then slumped 296074.34% in 2026.
- A 5-year view of Non Operating Income shows it stood at -$1.6 million in 2022, then surged by 103.61% to $57379.0 in 2023, then plunged by 53.09% to $26914.0 in 2024, then slumped by 81804.72% to -$22.0 million in 2025, then surged by 33.17% to -$14.7 million in 2026.
- The last three Non Operating Income figures came in at -$14.7 million (Q1 2026), -$22.0 million (Q4 2025), and -$8260.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | -14.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.70 Mn |
| Dec 31, 2025 | -21.99 Mn |
| Sep 30, 2025 | -8,260.00 |
| Jun 30, 2025 | -3,993.00 |
| Mar 31, 2025 | 4,965.00 |
| Dec 31, 2024 | 26,914.00 |
| Sep 30, 2024 | 69,719.00 |
| Jun 30, 2024 | 48,397.00 |
| Mar 31, 2024 | 91,194.00 |
| Dec 31, 2023 | 57,379.00 |
| Sep 30, 2023 | 24,955.00 |
| Jun 30, 2023 | 27,682.00 |
| Mar 31, 2023 | 26,110.00 |
| Mar 31, 2022 | -1.59 Mn |
| Dec 31, 2021 | 2.55 Mn |
| Sep 30, 2021 | -312,323.00 |
| Jun 30, 2021 | -458,371.00 |
| Mar 31, 2021 | -782,463.00 |